Lidocaine 4% Patch
NDC Package 85509-2014-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Lidocaine 4% Patch is adults and children 12 years of age or over:Clean and dry the affected areaOpen pouch and remove one patchApply 1 patch at a time to affected area; not more than 3 to 4 times dailyReseal pouch containing unused patches after each useRemove patch from the skin after at most 8-hour applicationChildren under 12 years of age:Consult a doctor. Marketed by Phoenix Rx Llc, this product is identified by NDC 85509-2014 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
85509-2014-3
Package Description
6 POUCH in 1 BOX / 5 g in 1 POUCH
Product Code
85509-2014
11-Digit Billing Format
85509201403
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Lidocaine 4% Patch
Dosage Form
-
Usage Information
Adults and children 12 years of age or over:Clean and dry the affected areaOpen pouch and remove one patchApply 1 patch at a time to affected area; not more than 3 to 4 times dailyReseal pouch containing unused patches after each useRemove patch from the skin after at most 8-hour applicationChildren under 12 years of age:Consult a doctor

Regulatory & Marketing

Labeler Name
Phoenix Rx Llc
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-24-2021
End Marketing Date
05-24-2021
Listing Expiration
05-24-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85509-2014-3 identifies a specific commercial package of 6 pouch in 1 box / 5 g in 1 pouch of Lidocaine 4% Patch, labeled by Phoenix Rx Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Phoenix Rx Llc on May 24, 2021. The current certification is valid through May 24, 2021.

How is this Phoenix Rx Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85509201403. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
85509-2014-3
11-Digit CMS (5-4-2)
85509-2014-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.